Comprehensive Care – Why? and What? The doctor’s perspective

 

From Prof. Dr. Bernd Pohlmann, Halifax, Canada

 

Berlin (20. September 2008) – Epilepsy (= repeated unprovoked seizures) is a frequent neurological disorder with a world-wide prevalence of 0.5 to 0.8%. Epilepsy affects a human being in all dimensions. At the same time, even in the 21st century societies seem not to be prepared to deal with this disease leading to sudden unexpected “non-functioning” and occasionally frightening appearance. Despite enormous advances both in medical treatment and new techniques such as epilepsy surgery and stimulation procedures, 1/3 of all epilepsy patients remain refractory with all somatic and psychosocial sequel. They suffer frequently from psychiatric comorbidities (anxiety and depression) and significant stigmatisation. Unemployment and mortality rates are 2-3 times higher than in the general population. These facts translate into a significant public health and economic perspective. „Indirect costs“ due to comorbidity, loss of productivity, repeated counselling due to uncertainty, and unemployment account for 70% of all related health care costs. According to the most recent WHO report, epilepsy ranks 3rd within neuropsychiatric diseases (after cerebrovascular diseases and dementia) with regard to the amount of cumulated DALYs („disability-adjusted life years“).

 

Epilepsy care restricting to antiepileptic drugs and epilepsy surgery is too reductionistic to address this complex disease. Comprehensive epilepsy care (CEC) as a more holistic concept seems to be the appropriate answer to this: It “means to treat an affected individual as an integral human being with all his needs, impairments, wishes and potential within his social and professional environment… it links intervention in the narrower medical sense (AED, surgery) with non-medical intervention e.g. counselling, offering information, psychosocial assistance, rehabilitation…“ (Comprehensive Care for people with epilepsy, Libbey London-Paris 2001)

 

Comprehensive epilepsy care is not restricted to specific subgroups of epilepsies and therefore is as important for new-onset epilepsy, as for patients who are seizure-free, drug-refractory, or have significant comorbidities. It applies for all age groups.

 

The primary goals of CEC are to provide individually tailored treatment lines, to create self-awareness and coping strategies within the affected individual and finally to improve short and long-term quality of life. Prevention is the ultimative goal of CEC. Epilepsy centres as organized in the European Association of Epilepsy Centre (EAEC) are constantly striving for the best epilepsy care following the CEC concept. They try to realize this using a wide range of structures (outpatient services, short-term ward, long-term ward, long-term residential units, schools, vocational training centres, etc.) organized in a network. On an operational level they often have key components  such as 1) multidisciplinary teams, 2) frequent case conferences, 3) validated instruments and clinical pathways, 4) continuous evaluation and education, and 5) in some bigger centres accompanying research as quality standard.

 

Typical treatment domains beside standardized drug and surgical therapy are psychiatric treatment, diagnosis of pseudoseizure, coping strategies for emotional disturbances, and neuropsychological problems, non-medical treatment, vocational assessment and rehabilitation, self-educational program, and specific units for people with learning disabilities.

 

Currently the described epilepsy centres seem to be without any alternatives within the available health care systems. They represent models of holistic medicine which show life-long commitment to individuals and their families. Now, they are challenged to clearly position within a cost-effectiveness driven health care system and come up with an own poignant profile. Sophisticated documentation of all treatment steps and outcome-orientated research seem crucial to this approach. Innovative concepts such as “First seizure clinics” following a strict CEC strategy (from the very beginning) may be promising undertakings in this exciting process of redefining the role of epilepsy centres.

 

Pohlmann_1

 

Slide 1: Burden of disease.

 

 

Pohlmann_2

 

Slide 2: Comprehensive Epilepsy Care.

 

 

Pohlmann_3

 

Slide 3: Comprehensive Care.

 

 

 


 

Source: 8th European Congress on Epiteptology, Satellite Symposium: “Comprehensive Care of Epilepsy in Europe”, Berlin, 20. September 2008 (Medizin und PR Kommunikation).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung